# Controlled Production Readiness Review — Formal Outcome

**Project Launch, Sprint 5.**

## Decision

# **NOT_READY_FOR_PRODUCTION_REVIEW**

Issued per the mission's entry-criteria clause. The Controlled Production
Readiness Review **was not conducted**, and therefore none of the six
board decisions (APPROVE_CONTROLLED_PRODUCTION / CONDITIONAL_APPROVAL /
CONTINUE_PILOT / RETRAIN / PAUSE / REJECT) was reached — a decision issued
without the review's required executed evidence would be meaningless at
best and dangerous at worst.

This decision does not constitute General Availability, and it does not
change the standing release decision in
`docs/general-availability/GENERAL_AVAILABILITY_REPORT.md` (CONDITIONAL
GO for one narrow, fully-disclosed pilot; NO GO for broad launch).

## Missing evidence (the list the entry gate requires)

Full per-criterion detail is in `ENTRY_CRITERIA.md`. The blocking gaps:

1. **No validated-candidate model.** The only trained model is
   `Experimental`, trained exclusively on one declared synthetic dataset —
   this environment holds zero real facility ACTIVE Ground Truth, so no
   model can structurally reach `Candidate`, let alone
   `Validated Candidate`.
2. **No locked validation report** over real clinical data (only the
   synthetic experimental run's reports, plus an unfilled template).
3. **No completed supervised advisory pilot** — infrastructure exists;
   no pilot has ever run at any facility with any user.
4. **No pilot final report** — the doc of that name describes the report
   endpoint, not a completed pilot.
5. **No documented human response data** — zero real acceptance/
   modification/rejection/decision-time/trust records.
6. **No ACTIVE image-backed baselines in any persistent environment**
   (the Atlas governance layer is built and tested; the library is empty
   outside test runs).
7. **No tested support ownership** (documentation exists; no named owner,
   no executed support simulation, alerting not wired to any destination).
8. **No exercised rollback** (documented and migration-tested against
   fresh databases; never executed against a running deployment — and no
   controlled production environment exists to execute it in).
9. **No standing registered artifact, active policy, or production
   database** — every registry row, policy, and baseline this program has
   ever created lives in ephemeral test/dev databases.

## What must happen before this review can begin

In dependency order:

1. **Stand up a persistent controlled environment** (real database, object
   storage, configured alert destination) — the prerequisite for every
   piece of executed operational evidence Sections 7–14 demand.
2. **Run a real facility engagement**: ingest real instrument images
   through Canvas, produce real ACTIVE Ground Truth through the
   double-blind annotation workflow, and activate real image-backed
   baselines through the Atlas lifecycle.
3. **Retrain on the real governed dataset** via the existing documented
   training command; the registration code will then grant `Candidate`
   on its own evidence.
4. **Run the Shadow protocol** (`docs/shadow-validation/`) to a locked
   validation report, then the **Advisor pilot**
   (`docs/advisory-pilot/PILOT_PROTOCOL.md`) to a real final report with
   real human response data.
5. **Execute and retain the operational evidence**: deployment, backup +
   restore, DR exercise, delivered alert, model/policy rollback, support
   simulation.
6. **Re-run this sprint.** With entry criteria met, conduct the full
   multidisciplinary review (Sections 1–18) and issue one of the six
   decisions.

## Owner and authority

This outcome was produced by the engineering review of repository
evidence. Reconvening the review requires the evidence above plus a
multidisciplinary board (clinical, engineering, security, legal, support)
— the six-way decision is that board's to make, not engineering's alone.

## Correct completion statement

LumenAI's Controlled Production Readiness Review was gated at entry:
the repository does not yet contain the real pilot, validation, baseline,
and operational evidence the review requires, so the board review was not
convened and **NOT_READY_FOR_PRODUCTION_REVIEW** was issued with the
missing-evidence list above. This outcome does not constitute General
Availability, and no capability has been marked production-ready without
production evidence.
